Lux Capital

Activity from announced rounds

Activity in this selectionAI · Series A

Lux Capital invests in companies emerging from the life sciences, physical sciences and computational sciences, including biotechnology, robotics, aerospace, defence and AI infrastructure.

Its investment approach includes small Seeds, Experiments and Optionality investments that let it engage with technology before a conventional venture case is established. The firm also makes thesis-driven investments and backs founders working on technically difficult problems.

Lux’s Riskgaming programme uses researched scenarios to examine how technological developments interact with geopolitics and national security. That perspective is especially relevant for founders whose commercial opportunity depends on scientific progress, industrial adoption or government demand.

Sources
Rounds participated in
5
Confirmed lead rounds
0
4 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$386M
5 disclosed · full round size, not this investor’s share

By stage

Series A5

By primary sector

Biotech3
AI1
Hardware1

By country

United States5

Rounds

5 in this selection
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A
Participant
Waypoint Bio

Develops AI-designed CAR T therapies for solid tumors using spatial biology

$20MSeries A
Role not disclosed
Cognichip

Develops Artificial Chip Intelligence (ACI) for semiconductor design

$60MSeries A
Role not disclosed
SkySelect

AI-powered procurement platform for airlines and MROs

$9MSeries A
Role not disclosed
Mendra

Develops and commercializes rare disease therapies using AI

$82MSeries A
Role not disclosed